β Cell transplantation and immunosuppression: Can't live with it, can't live without it

Journal of Clinical Investigation

Volumn 117, Issue 9, 2007, Pages 2380-2382

  Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RAPAMYCIN; TACROLIMUS;

B LYMPHOCYTE; CELL PROLIFERATION; CELL TRANSPLANTATION; DIABETES MELLITUS; GENETIC MODEL; HYPERGLYCEMIA; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; DIABETES MELLITUS; HUMANS; IMMUNOSUPPRESSION; INSULIN-SECRETING CELLS; REGENERATION;

EID: 34848878352     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33375     Document Type: Review

References (10)

1. Shapiro, A.M., et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238.
2. Bonner-Weir, S., and Weir, G.C. 2005. New sources of pancreatic beta-cells. Nat. Biotechnol. 23:857-861.
3. Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 429:41-46.
4. Teta, M., Rankin, M.M., Long, S.Y., Stein, G.M., and Kushner, J.A. 2007. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev. Cell. 12:817-826.
5. Nir, T., Melton, D.A., and Dor, Y. 2007. Recovery from diabetes in mice by β cell regeneration. J. Clin. Invest. 117:2553-2561. doi:10.1175/JCI32959.
6. Brownlee, M. 2003. A radical explanation for glucose-induced β cell dysfunction. J. Clin. Invest. 112:1788-1790. doi:10.1172/ JCI200320501.
7. Wajchenberg, B.L. 2007. beta-cell failure in diabetes and preservation by clinical treatment. Endocr. Rev. 28:187-218.
8. Brubaker, P.L., and Drucker, D.J. 2004. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology. 145:2653-2659.
9. DeFronzo, R.A., et al. 2005. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 28:1092-1100.
10. Kendall, D.M., et al. 2005. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care. 28:1083-1091.